Formycon AG
Pharmaceutical composition of an anti-VEGF antibody
Last updated:
Abstract:
The present invention relates to liquid pharmaceutical formulations for intravitreal injection of an anti-VEGF antibody which does not contain saccharides for use in the treatment of age-related macular degeneration.
Status:
Grant
Type:
Utility
Filling date:
13 Nov 2014
Issue date:
25 Feb 2020